Ghent University Academic Bibliography

Advanced

Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma

Raphael Marechal, John R Mackey, Raymond Lai, Pieter Demetter, Marc Peeters UGent, Marc Polus, Carol E Cass, Isabelle Salmon, Jacques Deviere and Jean-Luc Van Laethem (2010) CANCER. 116(22). p.5200-5206
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
cancer, pancreas, gemcitabine, surgery, deoxycytidine kinase, RANDOMIZED CONTROLLED-TRIAL, NUCLEOSIDE TRANSPORTER 1, DEOXYCYTIDINE KINASE, PHOSPHOLIPID PRECURSORS, CONCURRENT RADIATION, HEAD CARCINOMA, PHASE-II, CANCER, COMPARTMENTATION, CHEMOTHERAPY
journal title
CANCER
Cancer
volume
116
issue
22
pages
5200 - 5206
Web of Science type
Article
Web of Science id
000284047400011
JCR category
ONCOLOGY
JCR impact factor
5.131 (2010)
JCR rank
29/181 (2010)
JCR quartile
1 (2010)
ISSN
0008-543X
DOI
10.1002/cncr.25303
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
1193679
handle
http://hdl.handle.net/1854/LU-1193679
date created
2011-03-22 11:01:50
date last changed
2016-12-19 15:38:01
@article{1193679,
  author       = {Marechal, Raphael and Mackey, John R and Lai, Raymond and Demetter, Pieter and Peeters, Marc and Polus, Marc and Cass, Carol E and Salmon, Isabelle and Deviere, Jacques and Van Laethem, Jean-Luc},
  issn         = {0008-543X},
  journal      = {CANCER},
  keyword      = {cancer,pancreas,gemcitabine,surgery,deoxycytidine kinase,RANDOMIZED CONTROLLED-TRIAL,NUCLEOSIDE TRANSPORTER 1,DEOXYCYTIDINE KINASE,PHOSPHOLIPID PRECURSORS,CONCURRENT RADIATION,HEAD CARCINOMA,PHASE-II,CANCER,COMPARTMENTATION,CHEMOTHERAPY},
  language     = {eng},
  number       = {22},
  pages        = {5200--5206},
  title        = {Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma},
  url          = {http://dx.doi.org/10.1002/cncr.25303},
  volume       = {116},
  year         = {2010},
}

Chicago
Marechal, Raphael, John R Mackey, Raymond Lai, Pieter Demetter, Marc Peeters, Marc Polus, Carol E Cass, Isabelle Salmon, Jacques Deviere, and Jean-Luc Van Laethem. 2010. “Deoxycitidine Kinase Is Associated with Prolonged Survival After Adjuvant Gemcitabine for Resected Pancreatic Adenocarcinoma.” Cancer 116 (22): 5200–5206.
APA
Marechal, Raphael, Mackey, J. R., Lai, R., Demetter, P., Peeters, M., Polus, M., Cass, C. E., et al. (2010). Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma. CANCER, 116(22), 5200–5206.
Vancouver
1.
Marechal R, Mackey JR, Lai R, Demetter P, Peeters M, Polus M, et al. Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma. CANCER. 2010;116(22):5200–6.
MLA
Marechal, Raphael, John R Mackey, Raymond Lai, et al. “Deoxycitidine Kinase Is Associated with Prolonged Survival After Adjuvant Gemcitabine for Resected Pancreatic Adenocarcinoma.” CANCER 116.22 (2010): 5200–5206. Print.